FUNCTION OF AN INTERFERON-INDUCED UBIQUITION HOMOLOG
干扰素诱导的泛在同系物的功能
基本信息
- 批准号:3306922
- 负责人:
- 金额:$ 18.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1992
- 资助国家:美国
- 起止时间:1992-04-01 至 1995-03-31
- 项目状态:已结题
- 来源:
- 关键词:SDS polyacrylamide gel electrophoresis antisense nucleic acid autoradiography chemical conjugate chemical stability circular dichroism covalent bond crystallization cycloheximide enzyme mechanism gene induction /repression genetic library immunocytochemistry interferons isotope dilution method laboratory rabbit molecular cloning posttranslational modifications protein biosynthesis protein degradation protein purification protein structure function stable isotope double label tissue /cell culture ubiquitin western blottings
项目摘要
In responsive cells, type I and type II interferons induce 15-20
different proteins that are thought to mediate the host of cellular
regulatory effects such as changes in cell structure, activity,
differentiation, proliferative capacity, presentation of major
histocompatibility antigens, and anti-viral activity. However, the
functions for few of these proteins have been ascribed to date, although
such knowledge is fundamental to understanding and exploiting the
potential of the interferons as therapeutic agents. One such
interferon-induced protein of unknown function has a molecular weight of
15 kDa. This protein must be important for the ability of cells to mount
an interferon response since it is rapidly induced and its accumulation
parallels the appearance of antiviral activity. We have previously
proposed that this polypeptide, termed Ubiquitin Cross-Reactive Protein
(UCRP) because of its immunological and sequence similarity to ubiquitin,
represents a function-specific homolog of ubiquitin. More recently we
have shown that, like ubiquitin, UCRP is subject to both constitutive and
interferon-induced covalent conjugation to a spectrum of intracellular
proteins. The long-term objectives of this proposal are to understand
the role of UCRP conjugation in normal cellular regulation and in
response to interferon. The specific aims of the proposal are: (1) to
physically characterize recombinant UCRP stability by CD measurements and
to crystallize the protein for subsequent structure determination; (2) to
examine the dynamics of intracellular pools of free and conjugated UCRP
in normal and interferon-induced cells using affinity-purified polyclonal
antibodies against UCRP in conjunction with pulse-chase studies and
inhibition of UCRP induction with specific antisense oligonucleotide
probes; (3) to study the conjugation of UCRP to cytoskeletal proteins
using the anti-UCRP antibodies as immunohistochemical probes for
localization of the adducts; (4) to characterize the enzymological steps
in UCRP conjugation and isolate by affinity and FPLC methods the
enzyme(s) responsible for this unique post-translational modification;
and (5) to clone, sequence, and expressed recombinant UCRP conjugating
enzyme(s) using current molecular biological techniques. The resulting
characteristics of the UCRP conjugating system will be compared to the
parallel but distinct ubiquitin ligation pathway.
在响应细胞中,I型和II型干扰素诱导15-20
被认为可以介导细胞宿主的不同蛋白质
调节效应,例如细胞结构,活性的变化,
分化,增殖能力,主要表现
组织相容性抗原和抗病毒活性。 但是,
迄今为止,这些蛋白质中很少有功能已被归因于
这样的知识是理解和利用的基础
干扰素作为治疗剂的潜力。 一个这样的
干扰素诱导的未知功能蛋白具有分子量的
15 kda。 该蛋白对于细胞安装的能力必须很重要
干扰素反应迅速诱导并积累
与抗病毒活性的出现相似。 我们以前有
提出该多肽称为泛素交叉反应蛋白
(UCRP)由于其与泛素的免疫学和序列相似性,
代表泛素特定功能的同源物。 最近我们
已经表明,像泛素一样,UCRP受本构和
干扰素诱导的共轭与细胞内的光谱
蛋白质。 该提议的长期目标是了解
UCRP共轭在正常细胞调节和
对干扰素的响应。 该提案的具体目的是:(1)
通过CD测量值和
使蛋白质结晶以进行后续结构测定; (2)至
检查自由和共轭UCRP的细胞内池的动力学
在正常和干扰素诱导的细胞中,使用亲和纯化的多克隆
针对UCRP的抗体与脉搏追踪研究和
用特异性反义寡核苷酸抑制UCRP诱导
探针; (3)研究UCRP与细胞骨架蛋白的结合
使用抗UCRP抗体作为免疫组织化学探针
加合物的定位; (4)表征酶学步骤
在UCRP结合和通过亲和力和FPLC方法分离中
酶负责这种独特的翻译后修饰;
(5)克隆,序列和表达的重组UCRP结合
使用电流分子生物学技术的酶。 结果
将UCRP共轭系统的特征与
平行但独特的泛素连接途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ARTHUR L HAAS其他文献
ARTHUR L HAAS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ARTHUR L HAAS', 18)}}的其他基金
ABI 3100 Genetic Analyzer for Nucleic Acid Sequencing
用于核酸测序的 ABI 3100 基因分析仪
- 批准号:
6578668 - 财政年份:2003
- 资助金额:
$ 18.42万 - 项目类别:
FASEB CONFERENCE ON UBIQUITIN AND PROTEIN DEGRADATION
FASEB 泛素和蛋白质降解会议
- 批准号:
2024156 - 财政年份:1997
- 资助金额:
$ 18.42万 - 项目类别:
FUNCTION OF AN INTERFERON INDUCED UBIQUITIN HOMOLOG
干扰素诱导的泛素同系物的功能
- 批准号:
6519488 - 财政年份:1992
- 资助金额:
$ 18.42万 - 项目类别:
FUNCTION OF AN INTERFERON INDUCED UBIQUITIN HOMOLOG
干扰素诱导的泛素同系物的功能
- 批准号:
2184840 - 财政年份:1992
- 资助金额:
$ 18.42万 - 项目类别:
FUNCTION OF AN INTERFERON INDUCED UBIQUITIN HOMOLOG
干扰素诱导的泛素同系物的功能
- 批准号:
6202892 - 财政年份:1992
- 资助金额:
$ 18.42万 - 项目类别:
FUNCTION OF AN INTERFERON INDUCED UBIQUITIN HOMOLOG
干扰素诱导的泛素同系物的功能
- 批准号:
2184841 - 财政年份:1992
- 资助金额:
$ 18.42万 - 项目类别:
FUNCTION OF AN INTERFERON INDUCED UBIQUITIN HOMOLOG
干扰素诱导的泛素同系物的功能
- 批准号:
6386298 - 财政年份:1992
- 资助金额:
$ 18.42万 - 项目类别:
FUNCTION OF AN INTERFERON INDUCED UBIQUITIN HOMOLOG
干扰素诱导的泛素同系物的功能
- 批准号:
6920554 - 财政年份:1992
- 资助金额:
$ 18.42万 - 项目类别:
FUNCTION OF AN INTERFERON INDUCED UBIQUITIN HOMOLOG
干扰素诱导的泛素同系物的功能
- 批准号:
2392167 - 财政年份:1992
- 资助金额:
$ 18.42万 - 项目类别:
FUNCTION OF AN INTERFERON INDUCED UBIQUITIN HOMOLOG
干扰素诱导的泛素同系物的功能
- 批准号:
2684995 - 财政年份:1992
- 资助金额:
$ 18.42万 - 项目类别:
相似国自然基金
反义寡核苷酸—核酸适配体嵌合体的靶向分子设计与催化降解机理研究
- 批准号:22307124
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
维生素E-PEG修饰自组装反义核酸药物靶向MAPK14和BChE治疗神经炎症诱发阿尔兹海默症的应用基础研究
- 批准号:22207006
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
维生素E-PEG修饰自组装反义核酸药物靶向MAPK14和BChE治疗神经炎症诱发阿尔兹海默症的应用基础研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
持续碱基配对竞争降低反义锁核酸药物脱靶毒性的研究
- 批准号:52203187
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
持续碱基配对竞争降低反义锁核酸药物脱靶毒性的研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
OLIGONUCLEOTIDE MANIPULATION OF TUMOR CELL RADIORESISTANCE
寡核苷酸调控肿瘤细胞辐射抗性
- 批准号:
6443862 - 财政年份:2001
- 资助金额:
$ 18.42万 - 项目类别:
OLIGONUCLEOTIDE MANIPULATION OF TUMOR CELL RADIORESISTANCE
寡核苷酸调控肿瘤细胞辐射抗性
- 批准号:
6300542 - 财政年份:2000
- 资助金额:
$ 18.42万 - 项目类别:
OLIGONUCLEOTIDE MANIPULATION OF TUMOR CELL RADIORESISTANCE
寡核苷酸调控肿瘤细胞辐射抗性
- 批准号:
6334986 - 财政年份:2000
- 资助金额:
$ 18.42万 - 项目类别: